Flores, Zosima M.
HRN: 13-32-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/17/2024
10/24/2024
IV
300mg
Q6
Soft Tissue Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes